Arrhythmias & electrophysiology

Direct-to-Participant Enrollment in a Virtual Trial: Lessons Learned From the Heartline Study

JACC AdvPublished randomized trial

Authors' conclusion

The Heartline Study demonstrated the ability to recruit large numbers of participants aged ≥65 years. A direct-to-participant approach across multiple channels achieved excellent gender and geographic diversity, enrolling a higher percentage of women than typical cardiology trials and participation from rural areas. However, less racial and ethnic representation was achieved, highlighting the need for additional strategies to meet this goal. Future trials may consider such multichannel recruitment approaches to support decentralized clinical trials. (A Study to Investigate if Early Atrial Fibrillation [AF] Diagnosis Reduces Risk of Events Like Stroke in the Real-World; NCT04276441).

Study context

Population
U.S. adults aged ≥65 years with an iPhone and Medicare coverageparticipants completing enrollment (February 2020-December 2022), 321,272 applications installed, 28,155 completed baseline demographic assessments
Participants
34,244 adults
Methodological detailsdecentralized, direct-to-participant recruitment, multichannel
  • Decentralized
  • Direct-to-participant recruitment
  • Multichannel

Primary result

As reported in the abstract

Enrollment · February 2020-December 2022

Heartline Study applications installed

321,272

Participants completing enrollment

34,244

11%

Completed baseline demographic assessments, of those enrolled

82%

28,155/34,244

Further findings

Participant demographics (of those completing baseline demographic assessments)

Women
54.2% (15,258/28,155)
White
93.0% (26,192/28,155)
Asian
2.8% (781/28,155)
Black
2.7% (747/28,155)
Hispanic
2.5% (699/28,155)
Broad geographic representation throughout the United States was achieved

Original publication

Direct-to-Participant Enrollment in a Virtual Trial: Lessons Learned From the Heartline Study. JACC Adv. Published 23 March 2026. doi:10.1016/j.jacadv.2026.102662

Summarised from the published abstract; every number is checked against it

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.